Theralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory
/PRNewswire/ -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay...
United States United Kingdom Mick Ruxin Mattia Cremona Biopharma Laboratory Theralink Technologies Inc
Source: prnewswire.com